IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on August 1, 2008
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1515

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.07-1515v1
49/8/3379    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patil, K. A
Right arrow Articles by Schwartzman, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patil, K. A
Right arrow Articles by Schwartzman, M. L.

Article

Heme Oxygenase-1 Induction Attenuates Corneal Inflammation and Accelerates Wound Healing after Epithelial Injury

Kiran A Patil 1, Lars Bellner 1, Giuseppe Cullaro 1, Katherine Gotlinger 2, Michael W Dunn 1, and M. Laniado Schwartzman 3*

1 Pharmacology, New York Medical College, Valhalla, New York, United States
2 New York Medical College, Valhalla, New York, United States
3 New York Medical College, Department of Pharmacology, Grassland Road, BSB 530, Valhalla, New York, 10595, United States

* To whom correspondence should be addressed. E-mail: michal_schwartzman{at}nymc.edu.


   Abstract

Purpose: Heme oxygenase (HO) is considered a fundamental endogenous immunomodulatory, cytoprotective and anti-inflammatory system. This protective function is primarily ascribed to the inducible HO-1. We examined the effect of HO-1 induction on corneal inflammation and wound healing in mice undergoing epithelial injury. Methods: C57BL6 mice were treated with SnCl2 one day prior to epithelial injury and once daily, thereafter. The corneal epithelium was removed using an Alger Brush in anesthetized mice. Re-epithelialization was measured by fluorescein staining. The inflammatory response was examined by histology and quantified by the myeloperoxidase assay. Inflammatory lipid mediators were detected and quantified by LC-MS-MS-based lipidomic analysis. HO-1 expression was assessed by real-time PCR and HO activity was determined by measuring HO-dependent carbon monoxide (CO) production. Results: Epithelial injury caused a time-dependent transient increase in HO-1 expression and HO activity which was significantly amplified by treatment with SnCl2 resulting in a 2-3-fold increase in mRNA levels and a similar increase in corneal HO activity. Induction of HO-1 was associated with a significant acceleration of wound healing when compared with a vehicle-treated group and with attenuation of the inflammatory response evidenced by a significant decrease in the number of infiltrating cells and by a significant reduction in the expression and production of pro-inflammatory lipid mediators and cytokines. Conclusions: We conclude that increased expression of HO-1 provides a mechanism that modulates inflammation and promotes wound closure; pharmacological amplification of this system may constitute a novel strategy to treat corneal inflammation while accelerating wound repair following injury.

Key Words: anti-inflammatory agents, corneal wound healing, corneal epithelium, arachidonic acid







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology